Expression of bcl-2 — protein in small cell lung cancer

This publication has 17 references indexed in Scilit:

• Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival
  British Journal of Cancer, 1995
• Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas
  The Journal of Pathology, 1995
• Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer
  British Journal of Cancer, 1995
• Standard vs palliation chemotherapy in metastatic small cell lung cancer: An analysis on treatment efficacy and quality of life : Wolf, M., Pritsch, M., Drings, P., Schroeder, M., Hans, K., Hruska, E., Goerg, R., Eberhard, K., Mende, S., Hartung, G., Stolz, M., Havemann, K. Dept. of Int. Med., Philipps-Univ., Marburg, Germany
  Lung Cancer, 1994
• The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1994
• Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines
  Annals of Oncology, 1994
• bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer
  British Journal of Cancer, 1994
• bcl-2 Protein in Non-Small-Cell Lung Carcinoma
  New England Journal of Medicine, 1993
• KiSl—A novel monoclonal antibody which recognizes proliferating cells: Evaluation of its relationship to prognosis in mammary carcinoma
  The Journal of Pathology, 1992
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.
  Proceedings of the National Academy of Sciences, 1985